KS

Klaus Snej Jensen

Director Director DIN 07554059
DIN 07554059 First appointment Aug 2016 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2016
Shareholding value Locked Premium profile

About Klaus Snej Jensen

Data last updated:

Klaus Snej Jensen has 10 years in corporate governance. Formerly with 1 company, such as Medicamen Biotech Limited. Engaged in Technology. Contributes to corporate operations.

DIN 07554059
Primary Designation Director
First Appointment 12 Aug 2016
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Medicamen Biotech Limited L74899DL1993PLC056594
Director12 Aug 20161993Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medicamen Biotech Limited
Premium access

Shareholding and investment profile for Klaus Snej Jensen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Klaus Snej Jensen

Klaus Snej Jensen has 10 years in corporate governance. Formerly with 1 company, such as Medicamen Biotech Limited. Engaged in Technology. Contributes to corporate operations.

Klaus Snej Jensen is associated with 0 companies as a director.

Klaus Snej Jensen has expertise in Technology.

Klaus Snej Jensen has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available